MetLife Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $362K | Buy |
9,161
+17
| +0.2% | +$672 | ﹤0.01% | 1843 |
|
|
2025
Q1 | $276K | Sell |
9,144
-16
| -0.2% | -$483 | ﹤0.01% | 2021 |
|
|
2024
Q4 | $320K | Sell |
9,160
-203
| -2% | -$7.1K | ﹤0.01% | 2039 |
|
|
2024
Q3 | $375K | Buy |
9,363
+514
| +6% | +$20.6K | ﹤0.01% | 1942 |
|
|
2024
Q2 | $422K | Buy |
8,849
+1,008
| +13% | +$48K | ﹤0.01% | 1818 |
|
|
2024
Q1 | $340K | Buy |
7,841
+24
| +0.3% | +$1.04K | ﹤0.01% | 1903 |
|
|
2023
Q4 | $395K | Sell |
7,817
-109
| -1% | -$5.51K | ﹤0.01% | 1826 |
|
|
2023
Q3 | $360K | Buy |
7,926
+4
| +0.1% | +$181 | ﹤0.01% | 1832 |
|
|
2023
Q2 | $325K | Sell |
7,922
-178
| -2% | -$7.3K | ﹤0.01% | 1965 |
|
|
2023
Q1 | $289K | Buy |
8,100
+18
| +0.2% | +$643 | ﹤0.01% | 1990 |
|
|
2022
Q4 | $305K | Sell |
8,082
-205
| -2% | -$7.74K | ﹤0.01% | 1976 |
|
|
2022
Q3 | $367K | Hold |
8,287
| – | – | ﹤0.01% | 1864 |
|
|
2022
Q2 | $307K | Sell |
8,287
-292
| -3% | -$10.8K | ﹤0.01% | 2007 |
|
|
2022
Q1 | $318K | Buy |
+8,579
| New | +$318K | ﹤0.01% | 2065 |
|
|
2019
Q2 | – | Sell |
-171
| Closed | -$13.9K | – | 2514 |
|
|
2019
Q1 | $13.9K | Buy |
171
+1
| +0.6% | +$81 | ﹤0.01% | 2362 |
|
|
2018
Q4 | $9.19K | Sell |
170
-2
| -1% | -$108 | ﹤0.01% | 2386 |
|
|
2018
Q3 | $8.87K | Buy |
+172
| New | +$8.87K | ﹤0.01% | 2455 |
|